Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
Sari Bourne
ID:
1b832961-2619-30fb-68c4
/
Unclaimed
/
Organization:
Hogan Lovells
Published Works
18 articles
Too Much or Too Little: FDA Requests Comments on New Strategy Regarding Risk Information in DTC Ads
Focus on Regulation ·
August 22, 2017
cite
FDA Clarifies Requirements Regarding Submission of Manufacturing Establishment Information
Focus on Regulation ·
January 6, 2017
cite
A Renewed Focus on Quality: FDA Issues Proposed Rule Amending GLP Regulations
Focus on Regulation ·
August 31, 2016
cite
“Institutional Review Board (IRB) Written Procedures” Draft Guidance and NIH’s “Single IRB Policy” Offer Food for Thought to IRBs Charged with Oversight of Human Subjects Research
Focus on Regulation ·
August 8, 2016
cite
FDA Publishes Final Guidance on Physical Attributes of Generics
Focus on Regulation ·
June 18, 2015
cite
Previous
1
2
3
4
Next
